Shanghai Pharmaceuticals Holding Co.Ltd(601607) amiodarone hydrochloride injection approved for production

Shanghai Pharmaceuticals Holding Co.Ltd(601607) announced that the amiodarone hydrochloride injection of Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the drug registration certificate issued by the State Food and drug administration, and the drug was approved for production. Amiodarone hydrochloride injection is mainly used to treat severe arrhythmia.